Wang C, Lv T, Jin B, Li Y, Fan Z
Cell Death Discov. 2025; 11(1):28.
PMID: 39875357
PMC: 11775197.
DOI: 10.1038/s41420-025-02313-2.
Simond A, Lesage V, Verreault J, Loseto L, Houde M, Elliott A
Environ Sci Technol. 2025; 59(5):2389-2399.
PMID: 39874536
PMC: 11823453.
DOI: 10.1021/acs.est.4c08272.
Masenga S, Desta S, Hatcher M, Kirabo A, Lee D
Curr Res Physiol. 2024; 8:100133.
PMID: 39665027
PMC: 11629568.
DOI: 10.1016/j.crphys.2024.100133.
Posta E, Fekete I, Varkonyi I, Zold E, Barta Z
Cells. 2024; 13(20.
PMID: 39451206
PMC: 11505700.
DOI: 10.3390/cells13201688.
Yi Y, Feng Y, Shi Y, Xiao J, Liu M, Wang K
Toxics. 2024; 12(8).
PMID: 39195641
PMC: 11358978.
DOI: 10.3390/toxics12080539.
Adiponectin and Adiponectin Receptors in Atherosclerosis.
Gianopoulos I, Mantzoros C, Daskalopoulou S
Endocr Rev. 2024; 46(1):1-25.
PMID: 39106421
PMC: 11720176.
DOI: 10.1210/endrev/bnae021.
PPARs in Clinical Experimental Medicine after 35 Years of Worldwide Scientific Investigations and Medical Experiments.
Skoczynska A, Oldakowska M, Dobosz A, Adamiec R, Gritskevich S, Jonkisz A
Biomolecules. 2024; 14(7).
PMID: 39062500
PMC: 11275227.
DOI: 10.3390/biom14070786.
Investigation of Peroxisome Proliferator-Activated Receptor Genes as Requirements for Visual Startle Response Hyperactivity in Larval Zebrafish Exposed to Structurally Similar Per- and Polyfluoroalkyl Substances (PFAS).
Gutsfeld S, Wehmas L, Omoyeni I, Schweiger N, Leuthold D, Michaelis P
Environ Health Perspect. 2024; 132(7):77007.
PMID: 39046251
PMC: 11268134.
DOI: 10.1289/EHP13667.
Knockdown of PGBD5 inhibits the malignant progression of glioma through upregulation of the PPAR pathway.
Luo P, Yang J, Jian L, Dong J, Yin S, Luo C
Int J Oncol. 2024; 64(5).
PMID: 38577941
PMC: 11015917.
DOI: 10.3892/ijo.2024.5643.
Inhibition of the ILK-AKT pathway by upregulation of PARVB contributes to the cochlear cell death in Fascin2 gene knockout mice.
Liu R, Shang W, Liu Y, Xie Y, Luan J, Zhang T
Cell Death Discov. 2024; 10(1):89.
PMID: 38374196
PMC: 10876960.
DOI: 10.1038/s41420-024-01851-5.
An Overview of the Role of Peroxisome Proliferator-activated Receptors in Liver Diseases.
Changizi Z, Kajbaf F, Moslehi A
J Clin Transl Hepatol. 2024; 11(7):1542-1552.
PMID: 38161499
PMC: 10752810.
DOI: 10.14218/JCTH.2023.00334.
Dual PPAR delta/gamma agonists offer therapeutic potential for Alzheimer's disease.
Steinke I, Singh M, Amin R
Neural Regen Res. 2023; 19(6):1175-1176.
PMID: 37905851
PMC: 11467939.
DOI: 10.4103/1673-5374.386410.
Artificial Intelligence/Machine Learning-Driven Small Molecule Repurposing via Off-Target Prediction and Transcriptomics.
Rao M, McDuffie E, Sachs C
Toxics. 2023; 11(10).
PMID: 37888725
PMC: 10611213.
DOI: 10.3390/toxics11100875.
Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents.
Su J, Luo Y, Hu S, Tang L, Ouyang S
Int J Mol Sci. 2023; 24(17).
PMID: 37686185
PMC: 10487533.
DOI: 10.3390/ijms241713381.
Can coenzyme Q10 alleviate the toxic effect of fenofibrate on skeletal muscle?.
El-Bassouny D, Mansour A, Ellakkany A, Ayuob N, AbdElfattah A
Histochem Cell Biol. 2023; 160(2):147-158.
PMID: 37270716
PMC: 10386954.
DOI: 10.1007/s00418-023-02205-5.
PPAR-γ Agonist GW1929 Targeted to Macrophages with Dendrimer-Graphene Nanostars Reduces Liver Fibrosis and Inflammation.
Moreno-Lanceta A, Medrano-Bosch M, Simon-Codina B, Barber-Gonzalez M, Jimenez W, Melgar-Lesmes P
Pharmaceutics. 2023; 15(5).
PMID: 37242695
PMC: 10223394.
DOI: 10.3390/pharmaceutics15051452.
PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer.
Wang Z, Dong H, Li W, Han F, Zhao L
J Cancer. 2023; 14(6):1049-1061.
PMID: 37151397
PMC: 10158510.
DOI: 10.7150/jca.81430.
Computational pharmacology and computational chemistry of 4-hydroxyisoleucine: Physicochemical, pharmacokinetic, and DFT-based approaches.
Ahmad I, Kuznetsov A, Pirzada A, Alsharif K, Daglia M, Khan H
Front Chem. 2023; 11:1145974.
PMID: 37123881
PMC: 10133580.
DOI: 10.3389/fchem.2023.1145974.
Terpene-Containing Analogues of Glitazars as Potential Therapeutic Agents for Metabolic Syndrome.
Blokhin M, Kuranov S, Khvostov M, Fomenko V, Luzina O, Zhukova N
Curr Issues Mol Biol. 2023; 45(3):2230-2247.
PMID: 36975514
PMC: 10047834.
DOI: 10.3390/cimb45030144.
Targeting lipid metabolism as a new therapeutic strategy for inherited cardiomyopathies.
Gaar-Humphreys K, van den Brink A, Wekking M, Asselbergs F, van Steenbeek F, Harakalova M
Front Cardiovasc Med. 2023; 10:1114459.
PMID: 36760574
PMC: 9907444.
DOI: 10.3389/fcvm.2023.1114459.